Amprius Technologies Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
AMPX$9.17-3.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATEDS TATEMENTS OFCASHF LOWS
| Year ended December 31, | ||
|---|---|---|
| (In thousands) | 2023 | 2022 |
| Cash flows from operating activities: | ||
| Net loss | $(36,776) | $(17,332) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation | 3,880 | 2,709 |
| Depreciation and amortization | 1,806 | 1,539 |
| Amortization of deferred costs | 3,057 | 1,585 |
| Non-cash operating lease expense | 1,148 | 556 |
| Loss on write-off of deferred stock issuance costs | 581 | — |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (579) | (424) |
| Inventories | (230) | — |
| Deferred costs | (1,572) | (1,939) |
| Prepaid expenses and other current assets | 407 | (2,282) |
| Other assets | (9) | — |
| Accounts payable | 616 | 517 |
| Accrued and other current liabilities | 3,065 | 1,155 |
| Deferred revenue | 54 | 516 |
| Operating lease liabilities | (1,001) | (482) |
| Net cash used in operating activities | (25,553) | (13,882) |
| Cash flows from investing activities: | ||
| Purchase of property, plant and equipment | (17,550) | (1,481) |
| Net cash used in investing activities | (17,550) | (1,481) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock in connection with the Stock Purchase Agreement | 19,087 | — |
| Proceeds from issuance of common stock in connection with the At Market Issuance Sales Agreement | 371 | — |
| Payment of financing costs in connection with the Stock Purchase and At Market Issuance Sales agreements | (601) | (326) |
| Proceeds from issuance of common stock in connection with Business Combination and PIPE investment | — | 77,884 |
| Payment of transaction and issuance costs in connection with Business Combination and PIPE investment | — | (6,946) |
| Proceeds from exercise of stock options | 310 | 44 |
| Proceeds from exercise of stock warrants | 1 | 2,465 |
| Capital contributions from Amprius Holdings | — | 505 |
| Net cash provided by financing activities | 19,168 | 73,626 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (23,935) | 58,263 |
| Cash, cash equivalents and restricted cash, beginning of year | 69,752 | 11,489 |
| Cash, cash equivalents and restricted cash, end of year | $45,817 | $69,752 |
| Components of cash, cash equivalents and restricted cash: | ||
| Cash and cash equivalents | $45,761 | $69,696 |
| Restricted cash included in other assets | 56 | 56 |
| Total cash, cash equivalents and restricted cash | $45,817 | $69,752 |
| Supplemental disclosure of non-cash investing and financing information: | ||
| Unpaid purchases of property, plant and equipment | $1,864 | $83 |
| Unpaid financing costs in connection with a stock purchase agreement | $— | $263 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.